ENCOMPASS HEALTH CORP holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 70,830 | $7,173,662 | 0.08% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 9, 2025 |
| June 30, 2025 | 57,560 | $7,058,583 | 0.08% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 8, 2025 |
| Sept. 30, 2025 | 50,660 | $6,434,833 | 0.08% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 6, 2025 |
| Dec. 31, 2025 | 50,660 | $5,377,052 | 0.08% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 11, 2026 |
| March 31, 2026 | 50,660 | $4,900,342 | 0.10% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 5, 2026 |
| June 30, 2026 | 39,260 | $3,968,401 | 0.10% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 7, 2026 |
6 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.